The independent prognostic feature of high UGT2B17 gene expression in B-CLL cells demonstrated in independent patient cohorts was unexpected for a detoxification enzyme [6,7,8] and led us to postulate an influence on the BCR signaling pathway fundamental in promoting CLL progression. The gene discussed is UGT2B17; the disease is B-cell chronic lymphocytic leukemia.